Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mCRC × Clear all

Phase

Status

Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 434 Neoplasms 348 Carcinoma, Non-Small-Cell Lung 265 Colorectal Neoplasms 232 Lung Neoplasms 201 Prostatic Neoplasms 186 Carcinoma, Hepatocellular 163 Stomach Neoplasms 137 Multiple Myeloma 121 Pancreatic Neoplasms 115 Uterine Cervical Neoplasms 100 Leukemia, Myeloid, Acute 100 Rectal Neoplasms 99 Ovarian Neoplasms 90 Recurrence 89 Squamous Cell Carcinoma of Head and Neck 85 Neoplasm Metastasis 80 Glioblastoma 76 Head and Neck Neoplasms 73 Small Cell Lung Carcinoma 71 Esophageal Neoplasms 68 Endometrial Neoplasms 67 Brain Neoplasms 67 Triple Negative Breast Neoplasms 62 Colonic Neoplasms 62 Glioma 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Hematologic Neoplasms 52 Urinary Bladder Neoplasms 51 Motor Activity 51

Interventions

trifluridine tipiracil drug combination 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07116577 2025-08-11

Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC

Jinan Central Hospital

Phase 2 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡